Skip to main content

Disclaimer

In the Downloads section, the ‘Prior Submission’ file reflects the most recent measure submission to the former CBE. This file is provided for transparency. For any questions or clarification, please contact the designated measure steward.

Deep Vein Thrombosis Anticoagulation >= 3 Months

CBE ID
0581
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description

This measure identifies patients with deep vein thrombosis (DVT) on anticoagulation for at least 3 months after the diagnosis

    Measure Specs
      General Information
      1.14 Numerator

      Patients in the denominator who had at least 3 months of anticoagulation after acute deep vein thrombosis (DVT)

      1.15 Denominator

      Patients diagnosed with acute DVT more than 3 months prior to the end of the measurement year, who do not have contraindications to warfarin therapy (contraindications include: evidence of eye surgery, GI bleed, aortic dissection, cerebral aneurysm, pericarditis, bacterial endocarditis, pregnancy, bleeding diatheses, or head trauma)

      Exclusions

      Does not have contraindications to warfarin, which includes evidence of eye surgery, GI bleed, aortic dissection, cerebral aneurysm, pericarditis, bacterial endocarditis, pregnancy, bleeding diatheses, or head trauma anytime during the two years prior to the end of the measurement year through 90 days following onset of DVT

      Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed National Voluntary Consensus Standards For Clinically Enriched Administrative Data
      Initial Endorsement
      Last Updated
      Removal Date
      Steward Organization
      Resolution Health, Inc.
      Steward POC email
                Public Comments